Cingulate CING
NASDAQ CING
$5.20 -0.03 (-0.67%)
As of: Sep 22, 2026 · 10:26 AM EDT

Cingulate (CING) Non Operating Investment Income (2022)

Cingulate's (CING) quarterly Non Operating Investment Income came in at $3249.0 in Q3 2022, up 797.21% quarter-over-quarter from -$466.0 in Q2 2022.

Analysis

Cingulate (CING) Non Operating Investment Income (2022) Analysis & Trends

Cingulate (CING) has reported Non Operating Investment Income for 1 consecutive years, with $3249.0 the latest figure, recorded in Q3 2022.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Investment Income (Qtr)
1 Johnson & Johnson 650.65 Bn 629.89 Bn 17.26 Bn -
2 AbbVie 466.34 Bn 459.82 Bn 12.70 Bn -
3 Merck 362.11 Bn 355.02 Bn 12.21 Bn -
4 Novartis Ag 267.81 Bn 260.52 Bn 11.24 Bn -
5 Pfizer 157.31 Bn 145.91 Bn 10.94 Bn -
6 Bristol Myers Squibb 128.75 Bn 117.69 Bn 9.25 Bn -
7 Sanofi 51.80 Bn 44.84 Bn 10.79 Bn -
8 Revolution Medicines 40.91 Bn 40.91 Bn - -
9 BeOne Medicines 39.65 Bn 34.55 Bn 1.53 Bn -
10 Cingulate 72.81 Mn 72.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 3,249.00
Jun 30, 2022 -466.00
Mar 31, 2022 -2,948.00
API Access

Cingulate Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CING&period=max&api_key=YOUR_API_KEY